Crinetics Pharmaceuticals (CRNX) Gross Profit (2025 - 2026)

Crinetics Pharmaceuticals' (CRNX) quarterly Gross Profit came in at $10.5 million in Q1 2026, up 2818.01% year-on-year from $361000.0 in Q1 2025, and up 2818.01% quarter-over-quarter from $361000.0 in Q1 2025.

Crinetics Pharmaceuticals (CRNX) Gross Profit (2025 - 2026) Analysis & Trends

Crinetics Pharmaceuticals' Gross Profit history runs 2 years deep, the most recent figure standing at $10.5 million for Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Crinetics Pharmaceuticals 8.71 Bn 8.71 Bn 10.53 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 10.53 Mn
Mar 31, 2026 10.53 Mn
Mar 31, 2025 361,000.00
Mar 31, 2025 361,000.00